关注
Albert Manzano-Muñoz
Albert Manzano-Muñoz
PhD Student, IBEC
在 ibecbarcelona.eu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells
P Gener, S Montero, H Xandri-Monje, ZV Díaz-Riascos, D Rafael, ...
Nanomedicine: Nanotechnology, Biology and Medicine 24, 102106, 2020
542020
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance
JM Clara Alcon, Albert Manzano-Muñoz, Estela Prada, Jaume Mora, Aroa Soriano ...
Cell Death & Disease 11 (634), 2020
252020
A new CDK9 inhibitor on the block to treat hematologic malignancies
C Alcon, A Manzano-Muñoz, J Montero
Clinical Cancer Research 26 (4), 761-763, 2020
142020
MCL-1 inhibition overcomes anti-apoptotic adaptation to targeted therapies in B-cell precursor acute lymphoblastic leukemia
A Manzano-Muñoz, C Alcon, P Menéndez, M Ramírez, F Seyfried, ...
Frontiers in Cell and Developmental Biology 9, 695225, 2021
82021
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
A Manzano-Muñoz, J Yeste, MA Ortega, F Martín, A López, J Rosell, ...
NPJ Precision Oncology 6 (1), 90, 2022
42022
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)
P Velasco, F Bautista, A Rubio, Y Aguilar, S Rives, JL Dapena, A Pérez, ...
Frontiers in Pediatrics 11, 1269560, 2023
12023
A New Microfluidic Device to Facilitate Functional Precision Medicine Assays
A Manzano-Muñoz, J Yeste, MA Ortega, J Samitier, J Ramón-Azcón, ...
Cancer Immunotherapy: Methods and Protocols, 99-108, 2023
2023
Advancing cancer precision medicine through cell-based functional assays and microfluidics. Finding the needle in a haystack to improve pediatric leukemia treatment
A Manzano Muñoz
Universitat de Barcelona, 2022
2022
Iadademstat Inhibitor
C Alcon, A Manzano-Muñoz, J Montero
系统目前无法执行此操作,请稍后再试。
文章 1–9